The diagnosis and management of pleural empyema

Current Opinion in Infectious Diseases

Volumn 11, Issue 2, 1998, Pages 163-168

  Davies, Robert J O ^a   Gleeson, Fergus V ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; STREPTOKINASE;

DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; PLEURA EMPYEMA; REVIEW; SAFETY; THORACOSCOPY; THORAX DRAINAGE; TUBE;

EID: 0031968580     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199804000-00013     Document Type: Review

References (36)

1. Hippocrates . Aphorism 44. In: The genuine works of Hippocrates: the classics of surgery. Adams LB (editor). Birmingham, AL: Gryphon Editions Ltd.; 1985 pp. 768-771.
2. Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR and Empyema Subcommittee of the Research Committee of the British Thoracic Society. The clinical course and management of thoracic empyema. Q J Med 1996; 89:285-289.
3. Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis 1993; 148:813-817.
4. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997; 10:1150-1156.
5. Davies RJO, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community aquired pleural infection. Thorax 1997; 52:416-421. A prospective randomized controlled trial showing that intrapleural streptokinase improves the drainage of infected pleural collections in community-acquired infection.
6. Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med 1995; 151:1700-1708.
7. Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med 1980; 69:507-512.
8. Potts DE, Levin DC, Sahn SA. Pleural fluid pH in parapneumonic effusions. Chest 1976; 70:328-331.
9. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250.
10. van Sonnenberg E, Nakamoto SK, Mueller PR, Casola G, Neff CC, Friedman PJ, et al. CT-and ultrasound-guided catheter drainage of empyemas after chest-tube failure. Radiology 1984; 151:349-353.
11. Moulton JS, Benkert RE, Weisiger KH, Chambers JA. Treatment of complicated pleural fluid collections with image-guided drainage and intracavitary urokinase. Chest 1995; 108:1252-1259.
12. Ulmer JL, Choplin RH, Reed JC. Image-guided catheter drainage of the infected pleural space. J Thorac Imaging 1991; 6:65-73.
13. Landreneau RJ, Keenan RJ, Hazelrigg SR, Mack MJ, Naunheim KS. Thoracoscopy for empyema and hemothorax. Chest 1996; 109:18-24. An observational case series reporting the use of thorascopy for pleural effusion.
14. Sasse SA, Causing LA, Mulligan ME, Light RW. Serial pleural fluid analysis in a new experimental model of empyema. Chest 1996; 109:1043-1048. A novel animal model of empyema.
15. Simpson FG, Roomes D. Effects of streptokinase on pleural fluid viscosity. Med J Aus 1998; in press.
16. Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous. purulent, and sanguinous pleural exudations. J Clin Invest 1949: 28:173-190.
17. Aye RW, Froese DP, Hill LD. Use of purified streptokinase in empyema and hemothorax. Am J Surg 1991; 161:560-562.
18. Henke CA, Leatherman JW. Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions. Am Rev Respir Dis 1992; 145:680-684.
19. Alfageme I, Munoz F, Pena N, Umbria S. Empyema of the thorax in adults. Etiology, microbiologic findings, and management. Chest 1993; 103:839-843.
20. Willsie Ediger SK, Salzman G, Reisz G, Foreman MG. Use of intrapleural streptokinase in the treatment of thoracic empyema. Am J Med Sci 1990; 300:296-300.
21. Bergh NP, Ekroth R, Larsson S, Nagy P. Intrapleural streptokinase in the treatment of haemothorax and empyema. Scand J Thorac Cardiovasc Surg 1977; 11:265-268.
22. Ogirala RG, Williams MHJ. Streptokinase in a loculated pleural effusion. Effectiveness determined by site of instillation. Chest 1988; 94:884-886.
23. Bouros D, Schiza S, Panagou P, Drositis J, Siafakas N. Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema. Thorax 1994; 49:852-855.
24. Taylor RFH, Rubens MB, Pearson MC, Barnes NC. Intrapleural streptokinase in the management of empyema. Thorax 1994; 49:856-859.
25. Jerjes-Sanchez C, Ramirez-Rivera A, Elizalde JJ, Delgado R, Cicero R, Ibarra-Perez C, et al. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema. Chest 1996; 109:1514-1519.
26. Temes RT, Follis F, Kessler RM, Pett SB Jr, Wernly JA. Intrapleural fibrinolytics in management of empyema thoracis. Chest 1996; 110:102-106.
27. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med 1997; 155:291-295. A study comparing intrapleural streptokinase and urokinase for empyema. The sample size was not large enough to be certain that there is no difference between the two agents.
28. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997; 111:275-279. A non-randomized comparison of outcome with intrapleural streptokinase in patients with empyema compared with historical controls. No clear benefit was demonstrated, although the absence of randomization made interpretation of the data difficult.
29. Davies CWH, Lok S, Davies RJO. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med 1998; in press. A detailed report examining systemic fibrinolytic activity after the use of intrapleural streptokinase. No systemic fibrinolysis was detectable in a small patient sample.
30. Strange C, Allen ML, Harley R, Lazarchick J, Sahn SA. Intrapleural streptokinase in experimental empyema. Am Rev Respir Dis 1993; 147:962-966.
31. Yusuf S, Collins R, Peto R, Furberg C, Stampfer MJ, Goldhaber SZ, Hennekens CH. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J 1985; 6:556-585.
32. Collins R, Peto R, Parish S, Sleight P. ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials. Am J Cardiol 1993; 71:1127-1130.
33. Berglin E, Ekroth R, Teger Nilsson AC, William Olsson G. Intrapleural instillation of streptokinase. Effects on systemic fibrinolysis. Thorac Cardiovasc Surg 1981; 29:124-126.
34. Godley PJ, Bell RC. Major hemorrhage following administration of intrapleural streptokinase. Chest 1984; 86:486-487.
35. Mackenzie JW. Video-assisted thoracoscopy: treatment for empyema and hemothorax. Chest 1996; 109:2-3.
36. Wait MA, Sharma S, Hohn J, Dal Nogare A. A randomized trial of empyema therapy. Chest 1997; 111:1548-1551. A small randomized study comparing VATS with conventional medical management for empyema, suggesting that early thoracoscopic intervention may be associated with improved outcome, compared with standard therapy.